CARCINOMA, THYMIC

Clinical trials for CARCINOMA, THYMIC explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, THYMIC trials appear

Sign up with your email to follow new studies for CARCINOMA, THYMIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope drug enters first human tests for dozens of tough cancers

Disease control Ongoing

This is an early-stage study to find a safe dose of a new drug called KFA115, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced cancers that have stopped responding to standard treatments. The main goal is to check for side effects and determ…

Matched conditions: CARCINOMA, THYMIC

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

CARCINOMA, THYMIC

Get alerted when new CARCINOMA, THYMIC trials appear

New hope drug enters first human tests for dozens of tough cancers